TrialClinical pharmacokinetics2018
Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.
Mukul Minocha et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it